We are live on ! Find out more
ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

1 hedge funds and large institutions have $73 invested in Oncternal Therapeutics, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

1% less capital invested

Capital invested by funds: $74 → $73 (-$1)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBP
1
Union Bancaire Privee
Switzerland
$73 – – –

ONCT Hedge Fund Activity: Q3 2025 in Review

1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Oncternal Therapeutics, Inc. Common Stock (ONCT) for Q3 2025, worth a combined $73 — down 1.4% from $74 a quarter earlier.

Fund positioning in ONCT was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Oncternal Therapeutics, Inc. Common Stock (ONCT) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $73 of Oncternal Therapeutics, Inc. Common Stock stock for Q3 2025, down 1.4% quarter-over-quarter.
  • 0 funds opened new Oncternal Therapeutics, Inc. Common Stock positions in Q3 2025 and 0 closed out.

Based on aggregated 13F filings for Q3 2025.